4//SEC Filing
Kafka Steven J. 4
Accession 0001209191-18-010349
CIK 0001488613other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:06 PM ET
Size
5.3 KB
Accession
0001209191-18-010349
Insider Transaction Report
Form 4
Kafka Steven J.
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-02-13$61.55/sh−29,791$1,833,636→ 31,570 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017.
- [F2]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.10 to $62.41, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeother
Related Parties
1- filerCIK 0001585005
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:06 PM ET
- Size
- 5.3 KB